Alfonso Bellacosa, an adjunct professor in the college of science and technology at Temple University, is one of the many researchers working on a better understanding of epigenetic (de)regulation in cancer.

Carolyn Fang (left) co-leads CPC and works with a team of researchers studying cancer prevention and risk management.

As a researcher, Hossein Borghaei's laboratory is focused on molecular therapeutics, specifically, the immunotherapy for cancer, with particular emphasis on the clinical development and application of monoclonal antibodies.

Zeng-jie Yang studies cancer biology, with a focus on finding a more effective way to control tumor growth through targeting both tumor cells and their supporting stroma.

We believe that understanding basic mechanisms of immune development and function, through studying the biology of zebrafish, for example, will catalyze new opportunities for cancer treatment.